Mynurva Limited, which is part of the Deepbridge Life Sciences EIS portfolio, has recently partnered with Cambridge United to offer round-the-clock counselling to fans.
The League One club's Chief Executive, Alex Tunbridge, said the programme was already in place for staff - and was being extended to the supporter base.
Sky Medical Technology Ltd, which is part of the Deepbridge Technology Growth EIS portfolio, has recently been featured in an article by Medical Device Network regarding its self-adhesive device, called 'geko', a wearable neuromuscular electro stimulator that delivers a gentle electrical pulse in the leg to stimulate blood flow.
IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently raised £4.5 million in growth funding as it seeks to open offices across the United States and sell its ground-breaking remote eye test platform into the world's richest healthcare markets.
